Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations.

Subjects

Subjects :

Anti-Bacterial Agents administration & dosage
Cystic Fibrosis blood
Dose-Response Relationship, Drug
Humans
Infusions, Intravenous
Penicillanic Acid administration & dosage
Penicillanic Acid pharmacokinetics
Piperacillin administration & dosage
Piperacillin pharmacokinetics
Piperacillin, Tazobactam Drug Combination
Cystic Fibrosis drug therapy
Penicillanic Acid analogs & derivatives

Details

Language :

English

ISSN :

1873-5010

Volume :

15

Issue :

2

Database :

MEDLINE

Journal :

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Publication Type :

Editorial & Opinion

Accession number :

26490337

Full Text :

https://doi.org/10.1016/j.jcf.2015.10.005